USPSTF ups mammo screening age to 50

Nov 15, 2009

In a blow to mammography advocates, the U.S. Preventive Services Task Force (USPSTF) today changed its recommendation on mammography screening to advise women to start at age 50 rather than at 40.

Click here to read the rest of the article.

2025 10 02 Shahrvini Ai Vs Radiologist False Positives Thumbnail

False-positive DBT findings differ between AI, radiologists

October 2, 2025

Mammography Breast Ipad Patient 400

Women who skip first mammogram more likely to die of breast cancer

September 24, 2025

Breast Tomosynthesis Digital 400 (1)

Study finds AI not cost-effective for breast cancer screening

September 24, 2025

Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).

Adding MBI to DBT finds more breast cancers

September 23, 2025

False-positive DBT findings differ between AI, radiologists

By Amerigo Allegretto

False-positive DBT findings differed between AI and radiologists in population-based breast cancer screening.

October 2, 2025

2025 10 02 Shahrvini Ai Vs Radiologist False Positives Thumbnail

Women who skip first mammogram more likely to die of breast cancer

By Amerigo Allegretto

Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.

September 24, 2025

Mammography Breast Ipad Patient 400

Study finds AI not cost-effective for breast cancer screening

By Amerigo Allegretto

AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.

September 24, 2025

Breast Tomosynthesis Digital 400 (1)

Adding MBI to DBT finds more breast cancers

By Amerigo Allegretto

Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.

September 23, 2025

Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).

Echogenic rind on breast ultrasound holds diagnostic significance

By Amerigo Allegretto

An echogenic rind on breast ultrasound could spell malignancy for suspicious lesions.

September 17, 2025

Diagnostic transverse ultrasound image of the left breast in a 64-year-old woman shows irregular hypoechoic nonparallel mass with indistinct margins corresponding to palpable finding, assessed as BI-RADS category 4. Both readers assessed mass as having associated echogenic rind with complete circumferential extent (arrowheads). Ultrasound-guided biopsy of mass yielded diagnosis of invasive ductal carcinoma (intermediate grade, luminal A molecular subtype, no lymphovascular invasion).

DBT plus synthesized mammo leads to less false-positive recalls

By Amerigo Allegretto

A subanalysis of the TOSYMA trial found that DBT plus synthesized mammography leads to lower false-positive recall rates compared to digital mammography.

September 16, 2025

Breast Tomosynthesis Digital Social

AI interpretation leads to high NPV, recall rates in breast imaging

By Amerigo Allegretto

In a new study, an AI system reached near-perfect negative predictive value (NPV) in breast imaging but almost doubled the recall rate.

September 3, 2025

2025 09 03 Ajr Ai Breast Images Thumbnail

Spain’s Valencian Community selects Lunit AI software for breast screening program

By AuntMinnie.com staff writers

The Valencian Community, Spain’s third-largest healthcare region, has selected Lunit’s AI software for its breast cancer screening program.

September 2, 2025

Breast Mammo Computer 400

Experts issue appropriate use criteria for molecular breast imaging

The criteria offer use scenarios for technetium-99 (Tc-99m) sestamibi-based gamma camera imaging of the breast.

August 27, 2025

MRI model predicts breast tumor shrinkage patterns

By Amerigo Allegretto

An MRI model based on tumor microbiome images can predict breast tumor shrinkage patterns after neoadjuvant therapy.

August 26, 2025

2025 08 26 Radiology Mri Tumor Shrinkage Model Thumbnail

Calidar launches study of novel x-ray diffraction mammography system

By AuntMinnie.com staff writers

Diagnostic imaging startup Calidar has initiated the first in-human study of its x-ray diffraction 4D Mammography system.

August 19, 2025

Breast Mammo Computer 400

Combined MRI approach characterizes architectural distortions on mammo

By Amerigo Allegretto

A combined MRI approach achieved perfect sensitivity and negative predictive value in diagnosing architectural distortions found on mammography.

August 18, 2025

Page 1 of 573